10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, has scheduled its Q2 2025 earnings release for August 7, 2025, after market close. The company will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET to discuss financial results and business developments.
The earnings release will be available on the company's website before the call, and investors can access the live webcast through the investor relations section. A replay will be available for at least 45 days following the event.
10x Genomics (Nasdaq: TXG), leader nella biologia cellulare singola e spaziale, ha programmato il rilascio dei risultati del secondo trimestre 2025 per il 7 agosto 2025, dopo la chiusura del mercato. L'azienda terrà una conference call e una webcast alle 13:30 PT / 16:30 ET per discutere i risultati finanziari e gli sviluppi aziendali.
Il comunicato sui risultati sarà disponibile sul sito web della società prima della chiamata, e gli investitori potranno accedere alla diretta streaming tramite la sezione relazioni con gli investitori. Una registrazione sarà disponibile per almeno 45 giorni dopo l'evento.
10x Genomics (Nasdaq: TXG), líder en biología celular única y espacial, ha programado su publicación de resultados del segundo trimestre de 2025 para el 7 de agosto de 2025, después del cierre del mercado. La compañía realizará una llamada conferencia y una transmisión en vivo a las 1:30 PM PT / 4:30 PM ET para discutir los resultados financieros y desarrollos comerciales.
El comunicado de resultados estará disponible en el sitio web de la empresa antes de la llamada, y los inversores podrán acceder a la transmisión en vivo a través de la sección de relaciones con inversores. Una grabación estará disponible por al menos 45 días después del evento.
10x Genomics (나스닥: TXG)는 단일 세포 및 공간 생물학 분야의 선두주자로서 2025년 2분기 실적 발표를 2025년 8월 7일 시장 마감 후에 예정하고 있습니다. 회사는 재무 결과 및 사업 개발에 대해 논의하기 위해 오후 1:30 PT / 오후 4:30 ET에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
실적 발표는 콜 전에 회사 웹사이트에서 제공되며, 투자자들은 투자자 관계 섹션을 통해 라이브 웹캐스트에 접속할 수 있습니다. 이벤트 후 최소 45일간 다시보기 서비스가 제공됩니다.
10x Genomics (Nasdaq : TXG), un leader en biologie cellulaire unique et spatiale, a programmé la publication de ses résultats du deuxième trimestre 2025 pour le 7 août 2025, après la fermeture du marché. La société organisera une conférence téléphonique et un webcast à 13h30 PT / 16h30 ET pour discuter des résultats financiers et des développements commerciaux.
La publication des résultats sera disponible sur le site web de la société avant l'appel, et les investisseurs pourront accéder au webcast en direct via la section des relations investisseurs. Une rediffusion sera disponible pendant au moins 45 jours après l'événement.
10x Genomics (Nasdaq: TXG), ein führendes Unternehmen im Bereich der Einzelzell- und Raumbiologie, hat die Veröffentlichung der Ergebnisse für das zweite Quartal 2025 für den 7. August 2025 nach Börsenschluss geplant. Das Unternehmen wird eine Telefonkonferenz und einen Webcast um 13:30 Uhr PT / 16:30 Uhr ET abhalten, um die Finanzergebnisse und Geschäftsentwicklungen zu besprechen.
Die Ergebnisveröffentlichung wird vor der Telefonkonferenz auf der Unternehmenswebsite verfügbar sein, und Investoren können über den Bereich Investor Relations auf den Live-Webcast zugreifen. Eine Aufzeichnung wird mindestens 45 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
Live audio of the webcast will be available on the "Investors" section of the company website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-second-quarter-2025-financial-results-on-august-7-2025-302502761.html
SOURCE 10x Genomics, Inc.
FAQ
When will 10x Genomics (TXG) report Q2 2025 earnings?
What time is the 10x Genomics Q2 2025 earnings call?
How can I access the 10x Genomics Q2 2025 earnings call?
How long will the 10x Genomics Q2 2025 earnings call replay be available?
